ID

44775

Description

Study documentation part: On- Treatment This is a phase III study of BMS-354825 in subjects with chronic myelogenous leukemia in accelerated phase, or in myeloid or lymphoid blast phase or with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia who are resistant or intolerant to imatinib mesylate (Gleevec).Trial Number: NCT00123487. Drug: dasatinib. Phase 3

Keywords

  1. 8/2/15 8/2/15 -
  2. 8/6/15 8/6/15 -
  3. 11/18/21 11/18/21 -
Copyright Holder

Bristol-Myers Squibb

Uploaded on

November 18, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Advanced Chronic Myelogenous Leukemia (CML) NCT00123487 – On- Treatment

Advanced Chronic Myelogenous Leukemia (CML) NCT00123487 – On- Treatment

SUBJECT DETAILS
Description

SUBJECT DETAILS

Subject number:
Description

Subject number

Data type

integer

Alias
UMLS CUI-1
C1709561
Subject initial:
Description

Subject initial

Data type

text

Alias
UMLS CUI-1
C2986440
Visit date:
Description

Visit date

Data type

date

Alias
UMLS CUI-1
C0011008
UMLS CUI-2
C0545082

Similar models

Advanced Chronic Myelogenous Leukemia (CML) NCT00123487 – On- Treatment

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
SUBJECT DETAILS
Subject number
Item
Subject number:
integer
C1709561 (UMLS CUI-1)
Subject initial
Item
Subject initial:
text
C2986440 (UMLS CUI-1)
Visit date
Item
Visit date:
date
C0011008 (UMLS CUI-1)
C0545082 (UMLS CUI-2)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial